Jubilant Ingrevia partners with O2 Renewable to increase use of green energy
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
The institution will be spread over an area of more than 8 acres
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The overall transaction is expected to conclude over next 12-15 months subject to receipt of all relevant shareholder and regulatory approvals
Both the Ministries signed MoU for anaemia control among adolescent girls using Ayurveda interventions
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Project achieves 30% reduction in hospital acquired infections and 24% reduction in the incidence of multi-drug resistant organisms
Subscribe To Our Newsletter & Stay Updated